Merck (MRK +0.5%) gets a boost out of positive comments out of Barron's yesterday, saying that...

|About: Merck & Co Inc. (MRK)|By:, SA News Editor

Merck (MRK +0.5%) gets a boost out of positive comments out of Barron's yesterday, saying that promising new drugs and a strong dividend should keep investors buying it for some time to come. Moreover, Barron's adds, headcount reductions and synergies from its Schering-Plough acquisition of have gone a long way towards improving the company's margin and growth outlook. Although the stock is trading near 52-week highs, there still may be some life left in the shares.